Curatis is a specialty pharmaceutical company based in Switzerland.
“We focus on the acquisition, development and commercialisation of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases.
Curatis is engaged in two business areas:
Development business
Distribution business Europe, Switzerland
We are seeking to partner our late stage phase III biological asset corticorelin for the treatment of peritumoral brain edema.
We are seeking Rx products to be marketed in Europe and Switzerland
Address
LiestalSwitzerland
